Dogwood Therapeutics, Inc.
DWTX
$5.37
$1.1025.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.73M | -2.28M | -1.05M | -1.29M | -1.10M |
| Total Depreciation and Amortization | 12.20K | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 58.40K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.69M | 94.30K | 148.90K | 139.00K | 148.30K |
| Change in Net Operating Assets | -2.16M | 1.28M | 89.10K | 215.00K | -514.30K |
| Cash from Operations | -6.13M | -910.10K | -811.70K | -937.40K | -1.47M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 3.76M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 3.76M | -- | -- | -- | -- |
| Total Debt Issued | 15.32M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | -- | 1.45M | -- | 0.00 |
| Repurchase of Common Stock | -400.00 | -70.20K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15.32M | -70.20K | 1.45M | -- | 0.00 |
| Foreign Exchange rate Adjustments | -144.60K | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.81M | -980.40K | 640.70K | -937.40K | -1.47M |